Variant report

Variant	nsv962209
Chromosome Location	chr16:34365622-34389045
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr16:34369435-34369709	HepG2	liver:	n/a	chr16:34369584-34369595
2	CEBPB	chr16:34368818-34369342	ECC-1	luminal epithelium:	n/a	chr16:34369018-34369029
3	CEBPB	chr16:34369463-34369642	A549	lung:	n/a	chr16:34369584-34369595
4	CEBPB	chr16:34369427-34369724	ECC-1	luminal epithelium:	n/a	chr16:34369584-34369595
5	CEBPB	chr16:34368784-34369416	ECC-1	luminal epithelium:	n/a	chr16:34369018-34369029
6	CEBPB	chr16:34368953-34369173	HepG2	liver:	n/a	chr16:34369018-34369029
7	CTCF	chr16:34384400-34384550	HMEC	breast:	n/a	chr16:34384472-34384490 chr16:34384473-34384489 chr16:34384467-34384488 chr16:34384479-34384487 chr16:34384474-34384487
8	CTCF	chr16:34384420-34384570	NHEK	skin:	n/a	chr16:34384472-34384490 chr16:34384473-34384489 chr16:34384467-34384488 chr16:34384479-34384487 chr16:34384474-34384487
9	CTCF	chr16:34382520-34382670	GM12865	blood:	n/a	n/a
10	CTCF	chr16:34384421-34384572	NHEK	skin:	n/a	chr16:34384472-34384490 chr16:34384473-34384489 chr16:34384467-34384488 chr16:34384479-34384487 chr16:34384474-34384487
11	CTCF	chr16:34372845-34372884	GM10248	blood:	n/a	n/a
12	CTCF	chr16:34384254-34384260	LNCaP	prostate:	n/a	n/a
13	E2F4	chr16:34368918-34369186	MCF10A-Er-Src	breast:	n/a	n/a
14	EP300	chr16:34368714-34369504	ECC-1	luminal epithelium:	n/a	n/a
15	EP300	chr16:34368849-34369326	ECC-1	luminal epithelium:	n/a	n/a
16	ESR1	chr16:34368867-34369264	ECC-1	luminal epithelium:	n/a	n/a
17	ESR1	chr16:34368788-34369228	ECC-1	luminal epithelium:	n/a	n/a
18	ESR1	chr16:34368813-34369237	ECC-1	luminal epithelium:	n/a	n/a
19	FOS	chr16:34368780-34369319	MCF10A-Er-Src	breast:	n/a	chr16:34368939-34368948
20	FOS	chr16:34371974-34371981	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr16:34370319-34370518	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr16:34370409-34370587	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr16:34370318-34370609	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr16:34368826-34369319	MCF10A-Er-Src	breast:	n/a	chr16:34368939-34368948
25	FOS	chr16:34371891-34372008	MCF10A-Er-Src	breast:	n/a	chr16:34371959-34371968 chr16:34371960-34371969
26	FOS	chr16:34371891-34372103	MCF10A-Er-Src	breast:	n/a	chr16:34371959-34371968 chr16:34371960-34371969
27	FOS	chr16:34371903-34372103	MCF10A-Er-Src	breast:	n/a	chr16:34371959-34371968 chr16:34371960-34371969
28	FOS	chr16:34368839-34369241	MCF10A-Er-Src	breast:	n/a	chr16:34368939-34368948
29	FOS	chr16:34368816-34369319	MCF10A-Er-Src	breast:	n/a	chr16:34368939-34368948
30	FOS	chr16:34369553-34369623	MCF10A-Er-Src	breast:	n/a	n/a
31	FOXM1	chr16:34368740-34369504	ECC-1	luminal epithelium:	n/a	n/a
32	FOXM1	chr16:34368616-34369298	ECC-1	luminal epithelium:	n/a	n/a
33	GATA2	chr16:34372429-34372682	SH-SY5Y	brain:	n/a	n/a
34	GATA3	chr16:34369575-34369746	SH-SY5Y	brain:	n/a	n/a
35	GATA3	chr16:34369427-34369728	T-47D	breast:	n/a	n/a
36	GATA3	chr16:34372442-34372619	SH-SY5Y	brain:	n/a	n/a
37	GATA3	chr16:34368892-34369154	T-47D	breast:	n/a	n/a
38	HCFC1	chr16:34380501-34380875	K562	blood:	n/a	n/a
39	JUND	chr16:34371910-34372030	HepG2	liver:	n/a	chr16:34371959-34371968 chr16:34371960-34371969 chr16:34371958-34371969
40	JUND	chr16:34384766-34384839	HepG2	liver:	n/a	n/a
41	JUND	chr16:34368994-34369098	HepG2	liver:	n/a	n/a
42	MAFK	chr16:34366265-34366502	HepG2	liver:	n/a	n/a
43	MAX	chr16:34368856-34369228	ECC-1	luminal epithelium:	n/a	n/a
44	MAX	chr16:34377914-34378286	SK-N-SH	brain:	n/a	n/a
45	MAX	chr16:34368745-34369262	ECC-1	luminal epithelium:	n/a	n/a
46	MAX	chr16:34377991-34378554	SK-N-SH	brain:	n/a	n/a
47	MYC	chr16:34368862-34369302	MCF10A-Er-Src	breast:	n/a	n/a
48	MYC	chr16:34368866-34369273	MCF10A-Er-Src	breast:	n/a	n/a
49	NFIC	chr16:34368749-34369402	ECC-1	luminal epithelium:	n/a	n/a
50	NFIC	chr16:34368813-34369316	ECC-1	luminal epithelium:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:34380215-34380265	HAEpiC	amniotic membrane:	n/a
2	chr16:34380215-34380265	HAEpiC	amniotic membrane:	n/a
3	chr16:34378069-34378119	AG09319	gingival:	n/a
4	chr16:34378497-34378547	NHDF-neo	bronchial:	n/a
5	chr16:34378069-34378119	HRCEpiC	kidney:	n/a
6	chr16:34375288-34375338	Jurkat	blood:	n/a
7	chr16:34378497-34378547	GM19239	blood:	n/a
8	chr16:34378069-34378119	HEK293	kidney:	embryo
9	chr16:34375288-34375338	NT2-D1	testis:	n/a
10	chr16:34378069-34378119	H1-hESC	embryonic stem cell:	embryo
11	chr16:34375039-34375089	AG09319	gingival:	n/a
12	chr16:34375288-34375338	ProgFib	skin:	n/a
13	chr16:34378497-34378547	ovcar-3	ovarian:	n/a
14	chr16:34380215-34380265	SK-N-MC	brain:	n/a
15	chr16:34378497-34378547	HNPCEpiC	eye:	n/a
16	chr16:34378497-34378547	HMEC	breast:	n/a
17	chr16:34375288-34375338	HCM	heart:	n/a
18	chr16:34375288-34375338	AG10803	skin:	n/a
19	chr16:34380215-34380265	MCF-7	breast:	n/a
20	chr16:34375039-34375089	AoSMC	blood vessel:	n/a
21	chr16:34378497-34378547	NHBE	bronchial:	n/a
22	chr16:34378804-34378854	ECC-1	luminal epithelium:	n/a
23	chr16:34375039-34375089	Hepatocyte	liver:	n/a
24	chr16:34378497-34378547	Hepatocyte	liver:	n/a
25	chr16:34378069-34378119	BE2_C	brain:	n/a
26	chr16:34378497-34378547	AG04449	skin:	fetal
27	chr16:34375039-34375089	CMK	blood:	n/a
28	chr16:34380215-34380265	SAEC	small airway:	n/a
29	chr16:34378069-34378119	LNCaP	prostate:	n/a
30	chr16:34378497-34378547	ProgFib	skin:	n/a
31	chr16:34375039-34375089	SK-N-SH_RA	brain:	n/a
32	chr16:34378069-34378119	SK-N-SH_RA	brain:	n/a
33	chr16:34380215-34380265	PrEC	prostate:	n/a
34	chr16:34375039-34375089	AG04449	skin:	fetal
35	chr16:34375288-34375338	HEEpiC	esophagus:	n/a
36	chr16:34375039-34375089	MCF10A-Er-Src	breast:	n/a
37	chr16:34375288-34375338	H1-hESC	embryonic stem cell:	embryo
38	chr16:34375039-34375089	HEEpiC	esophagus:	n/a
39	chr16:34380215-34380265	GM12878	blood:	n/a
40	chr16:34380215-34380265	NT2-D1	testis:	n/a
41	chr16:34380215-34380265	T-47D	breast:	n/a
42	chr16:34378497-34378547	K562	blood:	n/a
43	chr16:34378069-34378119	HPAEpiC	pulmonary alveolar:	n/a
44	chr16:34378804-34378854	PrEC	prostate:	n/a
45	chr16:34378804-34378854	HEEpiC	esophagus:	n/a
46	chr16:34380215-34380265	NH-A	brain:	n/a
47	chr16:34378069-34378119	GM12892	blood:	n/a
48	chr16:34378069-34378119	HRE	kidney:	n/a
49	chr16:34380215-34380265	SK-N-SH	brain:	n/a
50	chr16:34375039-34375089	PrEC	prostate:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CTD-2144E22.5.1-14	chr16:34368885-34369446	NONHSAT142152
2	lnc-LINC00273-15	chr16:34383828-34384161	NONHSAT142158

Variant related genes	Relation type
ENSG00000261510	TF binding region
ENSG00000260449	TF binding region
ENSG00000261836	TF binding region
VN1R69P	TF binding region
ENSG00000261800	TF binding region
ENSG00000261510	CpG island
ENSG00000260449	CpG island
ENSG00000261836	CpG island
VN1R69P	CpG island
ENSG00000261800	CpG island

Extended variants
information (count: 680 )
Associated
traits (count: 126 )

Variant overlapped rSNPs/rCNVs (count:680 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs140621377	chr16:34366293-34366294	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs183498108	chr16:34366310-34366311	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs375605560	chr16:34366384-34366385	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs538365477	chr16:34368629-34368630	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs556513875	chr16:34368782-34368783	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs35341995	chr16:34368786-34368787	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs574936526	chr16:34368797-34368798	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs193286490	chr16:34368806-34368807	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs554398558	chr16:34368866-34368867	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs573065618	chr16:34368928-34368929	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
11	rs558622640	chr16:34368942-34368943	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
12	rs540389585	chr16:34368946-34368947	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
13	rs184674492	chr16:34368978-34368979	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
14	rs188342702	chr16:34369123-34369124	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
15	rs533445395	chr16:34369126-34369127	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
16	rs367743175	chr16:34369154-34369155	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
17	rs180682492	chr16:34369192-34369193	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
18	rs545561589	chr16:34369251-34369252	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs563663981	chr16:34369262-34369263	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs530972655	chr16:34369278-34369279	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs138740236	chr16:34369300-34369301	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs576853777	chr16:34369352-34369353	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs564234198	chr16:34369354-34369355	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs567906014	chr16:34369355-34369356	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs528796442	chr16:34369440-34369441	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs114610950	chr16:34369446-34369447	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs185512521	chr16:34369468-34369469	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs117710026	chr16:34369483-34369484	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs141371225	chr16:34369491-34369492	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs375754831	chr16:34369549-34369550	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs550311163	chr16:34369564-34369565	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs546614571	chr16:34369573-34369574	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs370415098	chr16:34369577-34369578	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs568615841	chr16:34369584-34369585	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs535807500	chr16:34369609-34369610	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs554285601	chr16:34369699-34369700	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs548387080	chr16:34369732-34369733	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs189718955	chr16:34369733-34369734	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs533871289	chr16:34369754-34369755	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs558702310	chr16:34369755-34369756	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs562002520	chr16:34369918-34369919	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs577149337	chr16:34369940-34369941	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs79361250	chr16:34370049-34370050	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs150759080	chr16:34370110-34370111	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs181816730	chr16:34370118-34370119	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs78395869	chr16:34370119-34370120	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs540052087	chr16:34370168-34370169	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs116536214	chr16:34370219-34370220	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs187094914	chr16:34370278-34370279	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs528758563	chr16:34370293-34370294	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:126)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Ductal carcinoma	22052326	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164920	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21364760	CNVD
Renal cell carcinoma	18194544	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD
Schizophrenia	20967226	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD
Bipolar disorder	19214233	CNVD
early-passage human iPS cells	21368824	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:34368800-34369200	Enhancers	NHEK	skin
2	chr16:34369200-34369400	Enhancers	HMEC	breast
3	chr16:34369200-34369400	Flanking Active TSS	NHEK	skin
4	chr16:34369200-34370600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr16:34369400-34369600	Enhancers	NHEK	skin
6	chr16:34369400-34369800	Flanking Active TSS	HMEC	breast
7	chr16:34369600-34369800	Flanking Active TSS	NHEK	skin
8	chr16:34369800-34370600	Enhancers	HMEC	breast
9	chr16:34369800-34370600	Enhancers	NHEK	skin
10	chr16:34370600-34371600	Weak transcription	NHEK	skin
11	chr16:34370600-34371800	Weak transcription	HMEC	breast
12	chr16:34371600-34372400	Enhancers	NHEK	skin
13	chr16:34371800-34372200	Enhancers	HMEC	breast
14	chr16:34374000-34387000	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
15	chr16:34374200-34376800	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr16:34374600-34374800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr16:34379000-34384200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr16:34380400-34385200	ZNF genes & repeats	Fetal Brain Female	brain
19	chr16:34380800-34383200	ZNF genes & repeats	iPS-18 Cell Line	embryonic stem cell
20	chr16:34381000-34382400	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr16:34382600-34382800	ZNF genes & repeats	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr16:34385200-34385800	ZNF genes & repeats	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr16:34386000-34386200	ZNF genes & repeats	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links